Webinars & Podcasts
Evaluating Usable Shelf-Life of Pathogen Reduced and LVDS Tested Platelet Components
Case Studies Assessing Platelet Availability from Blood Center and Hospital Perspectives
Review of Neonate to Pediatric Patient Outcomes Transfused with Amotosalen/UVA Treated Platelets
Hemostatic Efficacy of Pathogen Reduced Platelets in Pediatric Cardiopulmonary Bypass
Impact of Platelet Transfusion on Pulmonary Function of Hematology Oncology Patients: The PIPER Study (Wheeler)
Implementing Pathogen Reduced Platelets: A TSO (Transfusion Safety Officer) Perspective (Kosoglow)
Implementing Pathogen Reduced Platelets: A Transfusion Safety Officer Perspective
(Huber)
Merits and Pitfalls of Automated Bacterial Culture Methods in Improving Bacterial Safety of Platelet Concentrates
Impact of Anaerobic Culture of Platelets on Safety and Operations
Rationale for Pathogen Reduction- Blood Center and Transfusion Services Perspectives
Platelet Pathogen Reduction Technology Implementation at Stanford Blood Center
Platelet Component Bacterial Risk Control: An Evolution in Progress
Pathogen Reduced Platelet Implementation at Stanford Hospital
Implementing Pathogen Reduced (PR) INTERCEPT Platelets and Pediatric Considerations
Updating a Software Model to Estimate the Cost and Shelf Life Implications of New Platelet Technologies
Preparing Our Blood Supply for the Next Pandemic with Dr. Susan Stramer
Pathogen Reduction of Platelets: Guidance Compliance and Implementation
